Literature DB >> 24177464

Deep brain stimulation (DBS) at the interface of neurology and psychiatry.

Nolan R Williams, Michael S Okun.   

Abstract

Deep brain stimulation (DBS) is an emerging interventional therapy for well-screened patients with specific treatment-resistant neuropsychiatric diseases. Some neuropsychiatric conditions, such as Parkinson disease, have available and reasonable guideline and efficacy data, while other conditions, such as major depressive disorder and Tourette syndrome, have more limited, but promising results. This review summarizes both the efficacy and the neuroanatomical targets for DBS in four common neuropsychiatric conditions: Parkinson disease, Tourette syndrome, major depressive disorder, and obsessive-compulsive disorder. Based on emerging new research, we summarize novel approaches to optimization of stimulation for each neuropsychiatric disease and we review the potential positive and negative effects that may be observed following DBS. Finally, we summarize the likely future innovations in the field of electrical neural-network modulation.

Entities:  

Mesh:

Year:  2013        PMID: 24177464      PMCID: PMC3809784          DOI: 10.1172/JCI68341

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  163 in total

1.  Compulsions, Parkinson's disease, and stimulation.

Authors:  Luc Mallet; Valérie Mesnage; Jean-Luc Houeto; Antoine Pelissolo; Jérôme Yelnik; Cécile Behar; Marcella Gargiulo; Marie-Laure Welter; Anne-Marie Bonnet; Bernard Pillon; Philippe Cornu; Didier Dormont; Bernard Pidoux; Jean-François Allilaire; Yves Agid
Journal:  Lancet       Date:  2002-10-26       Impact factor: 79.321

Review 2.  Deep brain stimulation of the nucleus accumbens for the treatment of addiction.

Authors:  Ulf J Müller; Jürgen Voges; Johann Steiner; Imke Galazky; Hans-Jochen Heinze; Michaela Möller; Jared Pisapia; Casey Halpern; Arthur Caplan; Bernhard Bogerts; Jens Kuhn
Journal:  Ann N Y Acad Sci       Date:  2012-12-10       Impact factor: 5.691

3.  Deep brain stimulation of the nucleus accumbens and its usefulness in severe opioid addiction.

Authors:  J Kuhn; M Möller; J F Treppmann; C Bartsch; D Lenartz; T O J Gruendler; M Maarouf; A Brosig; U B Barnikol; J Klosterkötter; V Sturm
Journal:  Mol Psychiatry       Date:  2013-01-22       Impact factor: 15.992

4.  Double-blind clinical trial of thalamic stimulation in patients with Tourette syndrome.

Authors:  Linda Ackermans; Annelien Duits; Chris van der Linden; Marina Tijssen; Koen Schruers; Yasin Temel; Mariska Kleijer; Pieter Nederveen; Richard Bruggeman; Selma Tromp; Vivianne van Kranen-Mastenbroek; Herman Kingma; Danielle Cath; Veerle Visser-Vandewalle
Journal:  Brain       Date:  2011-03       Impact factor: 13.501

Review 5.  Pharmacological management of treatment-resistant obsessive-compulsive disorder.

Authors:  Anat Abudy; Alzbeta Juven-Wetzler; Joseph Zohar
Journal:  CNS Drugs       Date:  2011-07       Impact factor: 5.749

6.  Microlesion effect as a predictor of the effectiveness of subthalamic deep brain stimulation for Parkinson's disease.

Authors:  Tomasz Tykocki; Paweł Nauman; Henryk Koziara; Tomasz Mandat
Journal:  Stereotact Funct Neurosurg       Date:  2012-11-13       Impact factor: 1.875

7.  Deep brain stimulation of the subthalamic nucleus improves intrinsic alertness in Parkinson's disease.

Authors:  Bruno Fimm; Ines A Heber; Volker A Coenen; Christoph Fromm; Johannes Noth; Martin Kronenbuerger
Journal:  Mov Disord       Date:  2009-08-15       Impact factor: 10.338

8.  Effect of subthalamic nucleus stimulation on obsessive-compulsive disorder in a patient with Parkinson disease. Case report.

Authors:  Denys Fontaine; Vianney Mattei; Michel Borg; Daniel von Langsdorff; Marie-Noelle Magnie; Stéphane Chanalet; Philippe Robert; Philippe Paquis
Journal:  J Neurosurg       Date:  2004-06       Impact factor: 5.115

Review 9.  Deep brain stimulation for treatment-refractory obsessive-compulsive disorder: the search for a valid target.

Authors:  Nir Lipsman; Joseph S Neimat; Andres M Lozano
Journal:  Neurosurgery       Date:  2007-07       Impact factor: 4.654

10.  The need for a proper definition of a "treatment refractoriness" in tourette syndrome.

Authors:  Mauro Porta; Marco Sassi; Claudia Menghetti; Domenico Servello
Journal:  Front Integr Neurosci       Date:  2011-06-06
View more
  33 in total

Review 1.  Contemporary approaches to neural circuit manipulation and mapping: focus on reward and addiction.

Authors:  Benjamin T Saunders; Jocelyn M Richard; Patricia H Janak
Journal:  Philos Trans R Soc Lond B Biol Sci       Date:  2015-09-19       Impact factor: 6.237

Review 2.  Viral vector-based tools advance knowledge of basal ganglia anatomy and physiology.

Authors:  Rachel J Sizemore; Sonja Seeger-Armbruster; Stephanie M Hughes; Louise C Parr-Brownlie
Journal:  J Neurophysiol       Date:  2016-02-17       Impact factor: 2.714

Review 3.  Toward sophisticated basal ganglia neuromodulation: Review on basal ganglia deep brain stimulation.

Authors:  Claudio Da Cunha; Suelen L Boschen; Alexander Gómez-A; Erika K Ross; William S J Gibson; Hoon-Ki Min; Kendall H Lee; Charles D Blaha
Journal:  Neurosci Biobehav Rev       Date:  2015-02-12       Impact factor: 8.989

4.  Alim-Louis Benabid and Mahlon DeLong win the 2014 Lasker~DeBakey Clinical Medical Research Award.

Authors:  Sarah Jackson
Journal:  J Clin Invest       Date:  2014-09-08       Impact factor: 14.808

5.  Can cortical stimulation of inferior frontal cortex enhance proactive control?

Authors:  Vanessa M Johnen; Ethan R Buch; Franz-Xaver Neubert
Journal:  J Neurosci       Date:  2014-04-30       Impact factor: 6.167

Review 6.  Role of functional imaging in the development and refinement of invasive neuromodulation for psychiatric disorders.

Authors:  Nolan R Williams; Joseph J Taylor; Kayla Lamb; Colleen A Hanlon; E Baron Short; Mark S George
Journal:  World J Radiol       Date:  2014-10-28

Review 7.  Closed-loop rehabilitation of age-related cognitive disorders.

Authors:  Jyoti Mishra; Adam Gazzaley
Journal:  Semin Neurol       Date:  2014-12-17       Impact factor: 3.420

Review 8.  Deep brain stimulation for psychiatric diseases: what are the risks?

Authors:  Christian Saleh; Denys Fontaine
Journal:  Curr Psychiatry Rep       Date:  2015-05       Impact factor: 5.285

9.  STN vs. GPi Deep Brain Stimulation: Translating the Rematch into Clinical Practice.

Authors:  Nolan R Williams; Kelly D Foote; Michael S Okun
Journal:  Mov Disord Clin Pract       Date:  2014-04-01

10.  Reward circuit DBS improves Parkinson's gait along with severe depression and OCD.

Authors:  Nolan R Williams; Thomas R Hopkins; E Baron Short; Gregory L Sahlem; Jonathan Snipes; Gonzalo J Revuelta; Mark S George; Istvan Takacs
Journal:  Neurocase       Date:  2015-12-07       Impact factor: 0.881

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.